Publications by authors named "R Tehranchi"

Claim this Profile
D
Dasiglucagon Effects on QTc in Healthy Volunteers: A Randomized, Placebo-Controlled, Dose-Escalation, Double-Blind Study.
Ramin Tehranchi, Jonas Pettersson, Anita E Melgaard, Friedeborg Seitz, Anders Valeur

Curr Ther Res Clin Exp· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of the Novel Glucagon Analogue Dasiglucagon: Results of a Dedicated Immunogenicity Trial in Type 1 Diabetes.
Thomas R Pieber, Olubukola Ajala, Oren Steen, Dominik Dahl, Lone Eske Hansen, Ramin Tehranchi

Diabetes Technol Ther· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dasiglucagon, a next-generation glucagon analogue, for treatment of severe hypoglycaemia via an autoinjector device: Results of a phase 3, randomized, double-blind trial.
Timothy S Bailey, Julie Willard, Leslie J Klaff, Jenine Yager Stone, Anita Melgaard, Ramin Tehranchi

Diabetes Obes Metab· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dasiglucagon, a next-generation ready-to-use glucagon analog, for treatment of severe hypoglycemia in children and adolescents with type 1 diabetes: Results of a phase 3, randomized controlled trial.
Tadej Battelino, Ramin Tehranchi, Timothy Bailey, Klemen Dovc, Anita Melgaard

Pediatr Diabetes· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dasiglucagon-A Next-Generation Glucagon Analog for Rapid and Effective Treatment of Severe Hypoglycemia: Results of Phase 3 Randomized Double-Blind Clinical Trial.
Thomas R Pieber, Ronnie Aronson, Ulrike Hövelmann, Julie Willard, Leona Plum-Mörschel, Ramin Tehranchi

Diabetes Care· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis